Driving Performance of Depressed Patients who are Untreated or Receive Long-Term Antidepressant (SSRI/SNRI) Treatment

被引:14
作者
van der Sluiszen, Nick N. J. J. M. [1 ]
Wingen, Marleen [1 ]
Vermeeren, Annemiek [1 ]
Vinckenbosch, Frederick [1 ]
Jongen, Stefan [1 ]
Ramaekers, Johannes G. [1 ]
机构
[1] Maastricht Univ, Dept Neuropsychol & Psychopharmacol, Maastricht, Netherlands
关键词
antidepressants; depression; driving performance; long-term treatment; ROAD-TRAFFIC ACCIDENTS; PSYCHOMOTOR FUNCTION; MIRTAZAPINE; IMPAIRMENT; DISORDER; DRIVERS; ALCOHOL; YOUNG;
D O I
10.1055/s-0043-111600
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction Depression is a mental disorder likely to affect everyday functions. The present study aimed to assess actual driving performance of depressed patients who were without specific antidepressant treatment or received long-term antidepressant treatment. Methods A standardized on-the-road driving test was used to assess standard deviation of lateral position (SDLP) in 3 patient groups receiving either no antidepressant treatment (with or without benzodiazepine medication) or treatment with selective serotonin/noradrenalin reuptake inhibitors for a period of 6-52 weeks. Severity of depression was assessed using Beck's Depression Inventory and the Hamilton Depression Rating Scale. The performance of patient groups was compared to healthy controls. Results The mean SDLP of untreated and treated patients was significantly higher than that of healthy controls. Driving impairment in the long-term treated group was significantly less than in the untreated groups. SDLP was positively correlated to severity of depression across all groups. Discussion It is concluded that symptoms of depression are a major cause of driving impairment. Reductions in severity of depression through antidepressant treatment reduce severity of driving impairment.
引用
收藏
页码:182 / 188
页数:7
相关论文
共 50 条
  • [31] Differentiation of the pattern of cognitive impairment between depressed and non-depressed patients with dementia living in long-term care facilities
    Hudon, Carol
    Voyer, Philippe
    Tremblay, Isabelle
    Tardif, Sarah
    Carmichael, Pierre-Hugues
    AGING & MENTAL HEALTH, 2010, 14 (03) : 293 - 302
  • [32] Cerebrospinal neuropeptide Y and substance P in suicide attempters during long-term antidepressant treatment
    Olsson, A
    Regnéll, G
    Träskman-Bendz, L
    Ekman, R
    Westrin, Å
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 (06) : 479 - 485
  • [33] Short-term and long-term treatment for bipolar patients: beyond the guidelines
    Mendlewicz, J
    Souery, D
    Rivelli, SK
    JOURNAL OF AFFECTIVE DISORDERS, 1999, 55 (01) : 79 - 85
  • [34] LONG-TERM ANTABUSE TREATMENT OF ALCOHOL-DEPENDENT PATIENTS
    KRISTENSON, H
    ACTA PSYCHIATRICA SCANDINAVICA, 1992, 86 : 41 - 45
  • [35] Cognitive functions in patients with phenylketonuria in long-term treatment with tetrahydrobiopterin
    Gassio, R.
    Vilaseca, M. A.
    Lambruschini, N.
    Boix, C.
    Fuste, M. E.
    Campistol, J.
    MOLECULAR GENETICS AND METABOLISM, 2010, 99 : S75 - S78
  • [36] Iron Deficiency in Pediatric Patients in Long-Term Risperidone Treatment
    Calarge, Chadi Albert
    Ziegler, Ekhard E.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2013, 23 (02) : 101 - 109
  • [37] The burden of depressive symptoms in the long-term treatment of patients with schizophrenia
    Conley, Robert R.
    Ascher-Svanum, Haya
    Zhu, Baojin
    Faries, Douglas E.
    Kinon, Bruce J.
    SCHIZOPHRENIA RESEARCH, 2007, 90 (1-3) : 186 - 197
  • [38] Long-term treatment of thrombosis with enoxaparin in pediatric and adolescent patients
    Merkel, N
    Günther, G
    Schobess, R
    ACTA HAEMATOLOGICA, 2006, 115 (3-4) : 230 - 236
  • [39] A preliminary open study of the tolerability and effectiveness of nefazodone in major depressive disorder: Comparing patients who recently discontinued an SSRI with those on no recent antidepressant treatment
    Mischoulon, D
    Opitz, G
    Kelly, K
    Fava, M
    Rosenbaum, JF
    DEPRESSION AND ANXIETY, 2004, 19 (01) : 43 - 50
  • [40] Sexual Function during Long-Term Duloxetine Treatment in Patients with Recurrent Major Depressive Disorder
    Montejo, Angel-Luis
    Perahia, David G. S.
    Spann, Melissa E.
    Wang, Fujun
    Walker, Daniel J.
    Yang, Charles R.
    Detke, Michael J.
    JOURNAL OF SEXUAL MEDICINE, 2011, 8 (03) : 773 - 782